Immediate Impact

1 from Science/Nature 50 standout
Sub-graph 1 of 25

Citing Papers

From Cardiovascular-Kidney-Metabolic Syndrome to Cardiovascular-Renal-Hepatic-Metabolic Syndrome: Proposing an Expanded Framework
2025 Standout
Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy
2024 Standout
2 intermediate papers

Works of Amelia Ravera being referenced

Predictors of Sacubitril/Valsartan High Dose Tolerability in a Real World Population with HFrEF
2022
Involvement of Tissue Factor Pathway Inhibitor in the Coronary Circulation of Patients With Acute Coronary Syndromes
2003

Author Peers

Author Last Decade Papers Cites
Amelia Ravera 97 29 13 98 33 23 209
Ohad S. Bentur 74 33 2 47 28 27 204
Antonín Hluší 35 20 6 95 31 30 184
J Conard 60 55 7 83 63 23 182
Luigi Mancuso 109 89 11 96 22 20 290
Wilfried Roeloffzen 19 32 16 63 37 23 250
Siraj Mithoowani 31 40 5 171 27 24 280
Georgia Anastasiou 56 54 4 45 19 24 192
Bülent Özgönenel 32 68 7 74 17 19 243
José María Raya 20 52 21 83 20 16 192
Hubert Galinat 65 32 13 109 60 34 270

All Works

Loading papers...

Rankless by CCL
2026